Don't worry, these diseases can't spread to people.
Babies' genomes hold clues that can save their lives, but that same information could be used in far less noble ways. Where should we draw the line?
Catching cancer early doesn't always increase a patient's longevity and wellbeing.
The 20 ideas, trends, and breakthroughs that will shape our world in 2014
Tiny nanoparticles are a huge part of our lives, for better or for worse.
It takes real proof to back up even the simplest theories--these 10 studies show that the obvious can have not-so-obvious implications
Pigs are offering new possibilities for studying Alzheimer's disease
Turns out that a body reveals more details about its death than once thought
Cloning the green goo's factories for producing light-sensitive proteins could lead to more effective treatments for certain types of blindness
Jellyfish invasions, Internet auctions, god particles: Read about the year's biggest science stories before they happen. Bonus: How to decipher geeky jargon and when to buy a DeLorean
Will too many hot chili peppers kill you? Is the moon on the verge of erupting? PopSci tackles life's whys, hows and who-dunnits in this Q&A-style; feature
The author subjects himself to genetic tests, scans and other high-tech diagnostics to report on how the trend toward "personalized medicine" will affect us
We patrolled the halls of academe. We eavesdropped on the research grapevine. We asked scientists: Whose work is just plain brilliant?
This is the first time doctors have used DNA sequencing for emergency diagnosis and treatment.
Out of the wild
More than 50 of the most dangerous, disgusting, humiliating and just plain bad professions
The Big Question: How many people will it infect this year?
The first vaccine for one of the world's most deadly diseases is on the way
Neurologist Tally Lerman-Sagie saw her first cases of children having seizures a decade ago, but didn't have the technology to find their cause until now.
At-home personal genomics kits are available and affordable, but how relevant are the results?
The FDA shut down the company's medical devices last year. At SXSW, CEO Anne Wojcicki laid out a path forward for the business.
These gene-slicers may help tackle HIV, Alzheimer's, and brain cancer.
It's time to talk about informed consent.
As sequencing becomes more affordable, the way forward for diagnosis is not DNA snippets, but full genome workups